Characterization and Stability of Tanshinone IIA Solid Dispersions with Hydroxyapatite

被引:19
|
作者
Wang, Xiaopan [1 ]
Li, Li [2 ]
Huo, Wei [1 ]
Hou, Lulu [1 ]
Zhao, Zhiying [1 ]
Li, Weiguang [1 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 2, Dept Pharm, Nanjing 210028, Jiangsu, Peoples R China
来源
MATERIALS | 2013年 / 6卷 / 03期
基金
中国国家自然科学基金;
关键词
TanIIA; hydroxyapatite; solid dispersions; SALVIA-MILTIORRHIZA; COMPOSITE SCAFFOLDS; ENHANCEMENT; CRYPTOTANSHINONE; TEMPERATURE; SOLUBILITY; ABSORPTION; PHASE; ACID;
D O I
10.3390/ma6030805
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Solid dispersions of tanshinone IIA (TanIIA) using hydroxyapatite (HAp) as the dispersing carrier (TanIIA-HAp SDs) were prepared by the solvent evaporation method. The formed solid dispersions were characterized by scanning electron microscopy (SEM), differential scanning calorimetry analysis (DSC), X-ray powder diffraction (XRPD) and Fourier transforms infrared (FTIR) spectroscopy. The in vitro dissolution rate and the stability of TanIIA-HAp SDs were also evaluated. DSC and XRPD showed that TanIIA was changed from a crystalline to an amorphous form. FTIR suggested the presence of interactions between TanIIA and HAp in solid dispersions. The result of an in vitro dissolution study showed that the dissolution rate of TanIIA-HAp SDs was nearly 7.11-folds faster than free TanIIA. Data from stability studies for over one year of TanIIA-HAp SDs performed under room temperature revealed no significant differences in drug content and dissolution behavior. All these results indicated that HAp may be a promising carrier for improving the oral absorption of TanIIA.
引用
收藏
页码:805 / 816
页数:12
相关论文
共 50 条
  • [21] Total synthesis of tanshinone IIA
    Huang, He
    Song, Chuanjun
    Wang, Zhen
    Li, Mengyang
    Chang, Junbiao
    TETRAHEDRON LETTERS, 2020, 61 (28)
  • [22] Studies on the spectroscopic behavior of cryptotanshinone, tanshinone IIA, and tanshinone I
    Li, JF
    Wei, YX
    Xu, ZC
    Dong, C
    Shuang, SM
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2004, 60 (04) : 751 - 756
  • [23] Characterization of nifedipine solid dispersions
    Cilurzo, F
    Minghetti, P
    Casiraghi, A
    Montanari, L
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) : 313 - 317
  • [24] Preparation and characterization of solid dispersions
    Virgula, J
    Fekete, P
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 25 : S203 - S204
  • [25] Characterization of amorphous solid dispersions
    Liu X.
    Feng X.
    Williams R.O., III
    Zhang F.
    Journal of Pharmaceutical Investigation, 2018, 48 (1) : 19 - 41
  • [26] Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
    Chan, Szu-Erh
    Lai, Hung-Wen
    Su, Chin-Cheng
    Kuo, Shou-Jen
    Chien, Su-Yu
    Lin, Hui-Yi
    Chen, Dar-Ren
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011 : 1 - 9
  • [27] Thermal Stability of Amorphous Solid Dispersions
    Jelic, Dijana
    MOLECULES, 2021, 26 (01):
  • [28] STABILITY OF SOLID-LIQUID DISPERSIONS
    IORDACHE, O
    BOLOGA, V
    PLESU, V
    CHEMICAL ENGINEERING SCIENCE, 1988, 43 (10) : 2655 - 2659
  • [29] Tanshinone IIA in Acute Promyelocytic Leukemia
    Li, Jian
    Zhang, Kaiji
    Meng, Wentong
    Yang, Yiming
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 344 (04): : 283 - 288
  • [30] Physical stability of pharmaceutical formulations: solid-state characterization of amorphous dispersions
    Guo, Yushen
    Shalaev, Evgenyi
    Smith, Scott
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2013, 49 : 137 - 144